Navigation Links
ROYAL™ (Single Use Skin Staplers with Stainless Steel Staples)

ProductsROYAL™ (Single Use Skin Staplers with Stainless Steel Staples)
Company Autosuture
Item ROYAL™ (Single Use Skin Staplers with Stainless Steel Staples)
Features 
  • Single use.
  • Preloaded.
  • Available in one of three quantities: 12, 25 or 35 staples.
  • 2 Staple Sizes: 4.8mm (Regular) and 6.5mm (Wide) provide maximum wound closure flexibility.
  • 2 Staple Heights: 3.4mm (Regular) and 4.1mm (Wide) enhances cosmesis.
  • 6 units per box.
    • Description The ROYAL™ single-use skin stapler places one staple each time the instrument handles are activated. The staples first penetrate the skin and are then formed, thus holding the tissue together. The skin staples are available in two sizes: wide (having a clip span of 13.0 mm before closure) and regular (having a clip span of 9.9 mm before closure). The skin stapler comes preloaded and is available in one of three quantities: 12, 25 or 35 staples.
    Info Autosuture
    Customer Service: (800) 722-8772
    Web site: http://www.autosuture.com

    Related medicine products :

    1. Uric Acid (Uricase) (Single Reagent)
    2. Cholesterol (Single reagent)
    3. Dual Lock™ (Single And Double) Pivot Under-Table Shield
    4. SPRING-GRIP™ (Single Use Non-conductive Anchoring Devices)
    5. SURGINEEDLE™ (Single Use Pneumoperitoneum Needles)
    6. VERSAPORT™ Plus V2 (Single Use Converterless Trocar System)
    7. VERSAPORT™ Plus RPF (Single Use Converterless Trocar System)
    8. VERSAPORT™ Plus V2 RT (Single Use Obturators)
    9. VISIPORT™ Plus RPF (Single Use Optical Trocar With VERSAPORT™ Plus RPF Converterless Trocar Sleeve)
    10. BLUNTPORT Plus (Single Use Converterless 5 mm-12 mm Trocar System for Open Laparoscopy)
    11. THORACOPORT™ (Single Use Trocars With Non-conductive Sleeves)
    ...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
    ...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
    ...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
    ...atory and a worldwide leader in innovative laborat...sive test menu of highly complex and unique medica...by the University of Utah, ARUP Laboratories' clie...ity teaching hospitals and children's hospitals, m...
    Medicine Products:
    (Date:12/2/2008)...tatives from the fitness,company Burn Machine ( w...rs,Hospitals for Children in Chicago last month t...cause; The Burn Machine donated more than $1500,w...the first ever Shriners,Wheelchair Bodybuilding C...-bin/prnh/20081203/CLW007 ) , "We knew the...
    (Date:12/2/2008)...stantially higher rates of mental health problems ...from a systematic review and meta-analysis publish... studies over the past four decades containing dat...s people, Seena Fazel and colleagues of the Univer...84 homeless individuals based in the US, UK, mainl...
    (Date:12/2/2008)...oups of immigrants in Oslo. Compared with Norwegia...s are seen for risk factors and actual diseases. T...stitute of Public Health. Five of the largest immi... ethnic Norwegian population. The report was commi... The five immigrant groups in this study come fro...
    (Date:12/2/2008)...k, data review finds , , TUESDAY, Dec. 2... on the safety of the drug Trasylol (aprotinin), u...ry. , Trasylol is already the subject of contro...rom the market in 2007. , In the new study, Can... from 49 randomized clinical trials. They conclude...
    Breaking Medicine News(10 mins):Health News:Burn Machine Speed Bag Knocks 'em Out at Shriners Wheelchair Bodybuilding Camp 2Health News:Large health differences between population groups in Norway 2Health News:Large health differences between population groups in Norway 3Health News:Large health differences between population groups in Norway 4Health News:Another Study Warns of Risk From Cardiac Surgery Drug 2
    ...e field of cancer and our improved understanding o...east cancer, an effective strategy to treat the di...nt additions to a large family known as the metall... down tissues and have therefore been linked with ...
    ...vices (HHS) plans to stock vaccines and anti-viral... criticism for the past some days by Infectious Di... say that the stocks are not enough and HHS should...ocks in order to effectively prevent flu pandemic....
    ...en who had day labor got longer pain relief than w...r pain medicine. This could be due to the impact o...e the effectiveness of spinal-epidural pain medica...time of administration of the medication is regard...
    ...iller which was found to cause the death of Robert...arma the manufacturers of Vioxx were asked by the ...// to Mrs. Ernst. Over 5 years, about 20 million p...elling the drug in September 2004, after a clinica...
    Other Medicine News:Health News:Breast Cancer Advance 2Health News:Health and Human Services stockpiles 20 million bird flu Vaccines 2Health News:Timing Of Women's Labor May Determine Effectiveness Of Pain Medication 2
    (Date:12/2/2008)...tCall/ -- Micromet, Inc. (Nasdaq: MITI ), a biop...y antibodies for the treatment of cancer, inflamma... it has entered into an agreement expanding its Co...sbridge Capital Limited, a private investment grou...has committed to provide up to $75 million of capi...
    (Date:12/1/2008)...eGen has announced that an oral,presentation of ...clinical,trial of TG101348 in myeloproliferative ...merican Society of Hematology (ASH) Meeting. , ..., Title: A Phase I Study of TG10... JAK2-Selective Inhibitor, in Patients with, ...
    (Date:12/1/2008)... a two-way switch that, if turned off, causes lymp... they lose their identity and become more like blo...c. 1 Scientists at St.... that a certain differentiated cell type is so rea...stant expression of a gene called Prox1 to dissu...
    (Date:12/1/2008)...ay, December 9 at 11:00 am ET to Discuss Phase 2 S...ISCO, Calif., Dec. 1 S...biopharmaceutical company focused on the developme...ics, today announced new data from its studies of ...presented during the 50th American Society of Hema...
    Breaking Medicine Technology:Micromet Expands Committed Equity Financing Facility to $75 Million 2Micromet Expands Committed Equity Financing Facility to $75 Million 3Micromet Expands Committed Equity Financing Facility to $75 Million 4Micromet Expands Committed Equity Financing Facility to $75 Million 5Micromet Expands Committed Equity Financing Facility to $75 Million 6Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 2Reprogrammable Cell Type Depends on a Single Gene to Keep Its Identity 3Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 2Sunesis Announces New Data on Voreloxin for Acute Myeloid Leukemia To Be Presented at ASH 3Stern + Associates Signs New Clients to Health Care Practice 26591 1Stern + Associates Signs New Clients to Health Care Practice 26591 2Hurricane Devastation Touches the Nations Blood Supply 26589 1Hurricane Devastation Touches the Nations Blood Supply 26589 2AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 1AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 2AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 3AdvaMed 2008 Sponsor Participation Increases by 52 25 26587 4alli 28TM 29 Partners with Breast Cancer Network of Strength 28TM 29 to Support Women Challenged by Breast Cancer Weight Loss or Both 7814 1alli 28TM 29 Partners with Breast Cancer Network of Strength 28TM 29 to Support Women Challenged by Breast Cancer Weight Loss or Both 7814 2alli 28TM 29 Partners with Breast Cancer Network of Strength 28TM 29 to Support Women Challenged by Breast Cancer Weight Loss or Both 7814 3
    ...NEVA, Switzerland, May 2, 2007 – Merck,Seron...I data on,safinamide, a new agent in Phase III dev...sease symptoms, were presented by Professor,Fabriz...th Annual,Meeting in Boston, Massachusetts, USA. T...d, double blind, placebo-controlled,international...
    ...ublished today in the Journal of the National Canc...and, 2 May 2007 - In a study published today in,th...novative cancer,drug MabThera was shown to improve...less of the chemotherapy regimen used.1 The,review...as seen for,the first time in patients with mantle...
    Other Medicine Technology:Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 2Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 3Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 4Phase III Data on Safinamide in Parkinson’s Disease Presented,at American Academy of Neurology 59th Annual Meeting 5MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 2MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 3MabThera Significantly Increases Survival of Lymphoma Patients,Regardless of Chemotherapy Regimen 4